These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6327489)

  • 21. Structure-function relationships in glucagon. Re-evaluation of glucagon-(1-21).
    Frandsen EK; Thim L; Moody AJ; Markussen J
    J Biol Chem; 1985 Jun; 260(12):7581-4. PubMed ID: 2987259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptor occupancy and adenylate cyclase activation in rat liver and heart membranes by 10 glucagon analogs modified in position 2,3, 4, 25, 27 and/or 29.
    Robberect P; Damien C; Moroder L; Coy DH; Wünsch E; Christophe J
    Regul Pept; 1988 May; 21(1-2):117-28. PubMed ID: 2839870
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural requirements for glucagon receptor binding and activation of adenylate cyclase in liver. Study of chemically modified forms of the hormone, including N alpha-trinitrophenyl glucagon, an antagonist.
    Epand RM; Rosselin G; Hoa DH; Cote TE; Laburthe M
    J Biol Chem; 1981 Feb; 256(3):1128-32. PubMed ID: 6256384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of glucagon activation of adenylate cyclase in the presence of Mn2+.
    Houslay MD; Heyworth CM; Whetton AD
    FEBS Lett; 1983 May; 155(2):311-6. PubMed ID: 6303847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenylate cyclase activity in plasma membranes of chicken liver and of Mc-29 virus induced hepatoma.
    Chelibonova-Lorer H; Hadjiivanova N; Gavazova E
    Int J Biochem; 1982; 14(10):887-90. PubMed ID: 7128905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of surface charge and hydrophobic interaction in the activation of rat liver adenylate cyclase.
    Rubalcava B; Grajales MO; Cerbon J; Pliego JA
    Biochim Biophys Acta; 1983 Sep; 759(3):243-9. PubMed ID: 6309252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The glucagon receptor from liver can be functionally fused to caudate nucleus adenylate cyclase.
    Tolkovsky AM; Martin BR
    FEBS Lett; 1982 Dec; 150(2):337-42. PubMed ID: 6297980
    [No Abstract]   [Full Text] [Related]  

  • 28. Identification of distinct receptor complexes that account for high-and low-affinity glucagon binding to hepatic plasma membranes.
    Mason JC; Tager HS
    Proc Natl Acad Sci U S A; 1985 Oct; 82(20):6835-9. PubMed ID: 2995990
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucagon binding and adenylate cyclase activity in liver membranes from untreated and insulin-treated diabetic rats.
    Soman V; Felig P
    J Clin Invest; 1978 Mar; 61(3):552-60. PubMed ID: 205552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ontogeny of hepatic insulin and glucagon receptors and adenylate cyclase in rabbit.
    Ganguli S; Sinha MK; Sterman B; Harris P; Sperling MA
    Am J Physiol; 1983 Jun; 244(6):E624-31. PubMed ID: 6305205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitors of glucagon inactivation. Effect on glucagon--receptor interactions and glucagon-stimulated adenylate cyclase activity in liver cell membranes.
    Desbuquois B; Krug F; Cuatrecasas P
    Biochim Biophys Acta; 1974 Mar; 343(1):101-20. PubMed ID: 4364124
    [No Abstract]   [Full Text] [Related]  

  • 32. Study of receptor function by membrane fusion: the glucagon receptor in liver membranes fused to a foreign adenylate cyclase.
    Steiner S; Schramm M
    Methods Enzymol; 1985; 109():346-50. PubMed ID: 2985922
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of delta 9-tetrahydrocannabinol on glucagon receptor coupling to adenylate cyclase in rat liver plasma membranes.
    Hillard CJ; Bloom AS; Houslay MD
    Biochem Pharmacol; 1986 Aug; 35(16):2797-803. PubMed ID: 3017362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanism of action of cholera toxin and the mobile receptor theory of hormone receptor-adenylate cyclase interactions.
    Bennett V; O'Keefe E; Cuatrecasaş P
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):33-7. PubMed ID: 164020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient complexes. A new structural model for the activation of adenylate cyclase by hormone receptors (guanine nucleotides/irradiation inactivation).
    Martin BR; Stein JM; Kennedy EL; Doberska CA; Metcalfe JC
    Biochem J; 1979 Nov; 184(2):253-60. PubMed ID: 230831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of the glucagon receptor by covalent labeling with a radiolabeled photoreactive glucagon analogue.
    Demoliou-Mason C; Epand RM
    Biochemistry; 1982 Apr; 21(9):1996-2004. PubMed ID: 6284211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regeneration of the liver after carbon tetrachloride. Differences in adenylate cyclase and pancreatic hormone receptors.
    Mourelle M; Rubalcava B
    J Biol Chem; 1981 Feb; 256(4):1656-60. PubMed ID: 6161925
    [No Abstract]   [Full Text] [Related]  

  • 38. The lipid environment of the glucagon receptor regulates adenylate cyclase activity.
    Houslay MD; Hesketh TR; Smith GA; Warren GB; Metcalfe JC
    Biochim Biophys Acta; 1976 Jun; 436(2):495-504. PubMed ID: 179599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Photoaffinity labeling of the glucagon receptor with a new glucagon analog.
    Wright DE; Horuk R; Rodbell M
    Eur J Biochem; 1984 May; 141(1):63-7. PubMed ID: 6327311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenylate cyclase activity in crude liver membranes during chemical hepatocarcinogenesis.
    Marino A; Ravelingien N; De Cannière D; Préat V; Dehaye JP; Pector JC
    Carcinogenesis; 1991 Apr; 12(4):659-64. PubMed ID: 2013130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.